Clinical and neuropsychological features of corticobasal degeneration.
In this paper, we review the history, clinical, cognitive, imaging and neuropathological features of corticobasal degeneration (CBD). Additionally, we report new findings on the neuropsychological profile of 14 patients with CBD compared to 14 with Alzheimer's disease. Increasing awareness of this disorder has led to the realization that specific cognitive and imaging changes are common with CBD degeneration and that these changes help with clinical diagnosis.
Belfor
Nataliya
N
University of California San Francisco, Memory and Aging Center, 350 Parnassus Avenue, Suite 705, 94143, USA. nbelfor@memory.ucsf.edu
Amici
Serena
S
Boxer
Adam L
AL
Kramer
Joel H
JH
Gorno-Tempini
Maria Luisa
ML
Rosen
Howard J
HJ
Miller
Bruce L
BL
D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D001479:Basal Ganglia / Q000378:metabolism / Q000473:pathology; D001480:Basal Ganglia Diseases / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D015415:Biomarkers / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D003072:Cognition Disorders / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D006801:Humans
D015415:Biomarkers